{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:08:20Z","timestamp":1789232900879,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jhin.2026.07.011","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:23:10Z","timestamp":1784071390000},"page":"201-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Escherichia coli bacteraemia, Clostridioides difficile infection and antibiotic prescribing in South West London: a decade of surveillance before and after COVID-19"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7329-4826","authenticated-orcid":false,"given":"Mamdooh","family":"Alzyood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaccub","family":"Enum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2026.07.011_bib1","series-title":"ESPAUR report 2023 to 2024: lay summary","year":"2025"},{"key":"10.1016\/j.jhin.2026.07.011_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274248","article-title":"Global prevalence of nosocomial infection: A systematic review and meta-analysis","volume":"18","author":"Raoofi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2026.07.011_bib3","series-title":"Reducing gram-negative bloodstream infections: national ambitions and implementation guidance","year":"2017"},{"key":"10.1016\/j.jhin.2026.07.011_bib4","series-title":"HCAI Data Capture System: mandatory surveillance of healthcare-associated infections in England","year":"2025"},{"key":"10.1016\/j.jhin.2026.07.011_bib5","series-title":"Start Smart Then Focus: antimicrobial stewardship toolkit for English hospitals","year":"2015"},{"key":"10.1016\/j.jhin.2026.07.011_bib6","series-title":"UK Five-Year Antimicrobial Resistance strategy 2019\u20132024","year":"2019"},{"key":"10.1016\/j.jhin.2026.07.011_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13073-021-00947-2","article-title":"Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK","volume":"13","author":"Lipworth","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.jhin.2026.07.011_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/CMR.00082-09","article-title":"The changing epidemiology of Clostridium difficile infections","volume":"23","author":"Freeman","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhin.2026.07.011_bib9","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cmi.2024.03.018","article-title":"Epidemiology of Escherichia coli bloodstream infection antimicrobial resistance trends across South West England during the first 2 years of the coronavirus disease 2019 pandemic response","volume":"30","author":"Stanley","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2026.07.011_bib10","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1017\/ash.2022.361","article-title":"Healthcare-associated infections (HAIs) during the coronavirus disease 2019 (COVID-19) pandemic: a time-series analysis","volume":"3","author":"Sahrmann","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.jhin.2026.07.011_bib11","article-title":"Gram-negative bloodstream infections in healthcare: the relationship between antibiotic resistance, mortality, and novel serological biomarker","volume":"16","author":"Alt\u0131n","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jhin.2026.07.011_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004579","article-title":"Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: a modelling study","volume":"22","author":"Waterlow","year":"2025","journal-title":"PLOS Medicine"},{"key":"10.1016\/j.jhin.2026.07.011_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-023-15072-5","article-title":"Antimicrobial stewardship implementation before and during the COVID-19 pandemic in the acute care settings: a systematic review","volume":"23","author":"Elshenawy","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jhin.2026.07.011_bib14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cmi.2024.12.005","article-title":"Trends in antimicrobial consumption: long-term impact of the COVID-19 pandemic","volume":"31","author":"Tsuzuki","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2026.07.011_bib15","series-title":"AMR local indicators","year":"2025"},{"key":"10.1016\/j.jhin.2026.07.011_bib16","series-title":"Annual epidemiological commentary: Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including FY 2023\/24","year":"2025"},{"key":"10.1016\/j.jhin.2026.07.011_bib17","series-title":"Our five-year plan for the NHS in South West London 2023\u20132028","year":"2023"},{"key":"10.1016\/j.jhin.2026.07.011_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2451762","article-title":"Global burden and trends of the Clostridioides difficile infection-associated diseases from 1990 to 2021: an observational trend study","volume":"57","author":"Xia","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.jhin.2026.07.011_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhin.2018.10.024","article-title":"Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London","volume":"101","author":"Blandy","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2026.07.011_bib20","series-title":"Integrated Care Board (ICB) boundary changes and predecessor CCG mapping","year":"2022"},{"key":"10.1016\/j.jhin.2026.07.011_bib21","series-title":"English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report","year":"2025"},{"key":"10.1016\/j.jhin.2026.07.011_bib22","series-title":"HCAI Data Capture System: data definitions and methodology","year":"2023"},{"key":"10.1016\/j.jhin.2026.07.011_bib23","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"International Journal of Surgery"},{"key":"10.1016\/j.jhin.2026.07.011_bib24","series-title":"Point prevalence survey on healthcare-associated infections, antimicrobial use and AMS in England","year":"2023"},{"key":"10.1016\/j.jhin.2026.07.011_bib25","series-title":"Start Smart Then Focus: antimicrobial stewardship toolkit for inpatient care settings","year":"2023"},{"key":"10.1016\/j.jhin.2026.07.011_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on Clostridium difficile infection in England: an observational study","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhin.2026.07.011_bib27","article-title":"Hospital-acquired E. coli bacteraemia at a large UK NHS Trust. A return towards baseline following implementation of a 5-year quality improvement programme","volume":"5","author":"Gopaul","year":"2023","journal-title":"Infect Prev Pract"},{"key":"10.1016\/j.jhin.2026.07.011_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/postgradmedj-2017-135454","article-title":"Strategy to reduce E. coli bacteraemia based on cohort data from a London teaching hospital","volume":"94","author":"Hsu","year":"2018","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jhin.2026.07.011_bib29","series-title":"Antibiotic-resistant infections bounce back post-pandemic and associated deaths rise","year":"2023"},{"key":"10.1016\/j.jhin.2026.07.011_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhin.2024.02.008","article-title":"Not only COVID-19: a systematic review of anti-COVID-19 measures and their effect on healthcare-associated infections","volume":"147","author":"Ciccacci","year":"2024","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2026.07.011_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jhin.2024.02.010","article-title":"Impact of IPC practices on the prevalence of hospital-acquired infections during COVID-19: a systematic review: a systematic review and meta-analysis","volume":"147","author":"Teus","year":"2024","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2026.07.011_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2021.102479","article-title":"Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre","volume":"73","author":"Voona","year":"2022","journal-title":"Anaerobe"},{"key":"10.1016\/j.jhin.2026.07.011_bib33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14787210.2024.2368816","article-title":"Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019\u2013March 2023: a segmented interrupted time series analysis of over 53 million individuals","volume":"22","author":"Kurdi","year":"2024","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1016\/j.jhin.2026.07.011_bib34","series-title":"MRSA, MSSA and Gram-negative bacteraemia and CDI: infographics for England, FY 2024\/25","year":"2025"},{"key":"10.1016\/j.jhin.2026.07.011_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jhin.2016.12.008","article-title":"Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme","volume":"95","author":"Abernethy","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2026.07.011_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhin.2018.10.013","article-title":"Effectiveness of behavioural interventions to reduce urinary tract infections and Escherichia coli bacteraemia for older adults across all care settings: a systematic review","volume":"102","author":"Jones","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2026.07.011_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.12968\/bjcn.2020.25.5.240","article-title":"Strategies to reduce Gram-negative infections: a community perspective","volume":"25","author":"Aziz","year":"2020","journal-title":"Br J Community Nurs"},{"key":"10.1016\/j.jhin.2026.07.011_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gtc.2021.02.010","article-title":"A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea","volume":"50","author":"Abad","year":"2021","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jhin.2026.07.011_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13690-024-01427-w","article-title":"Community antibiotic consumption in the European Union\/European Economic Area: late-pandemic rebound and seasonality analysis","volume":"82","author":"Vermeulen","year":"2024","journal-title":"Arch Public Health"},{"key":"10.1016\/j.jhin.2026.07.011_bib40","series-title":"ESPAUR report 2022 to 2023","year":"2023"},{"key":"10.1016\/j.jhin.2026.07.011_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.100991","article-title":"Data for action: the crucial role of hospitals in controlling Clostridioides difficile infection in England","volume":"6","author":"Otu","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jhin.2026.07.011_bib42","series-title":"Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2025)","year":"2025"},{"key":"10.1016\/j.jhin.2026.07.011_bib43","article-title":"Comparison of trends in Clostridioides difficile infections in hospitalised patients during the first and second waves of the COVID-19 pandemic: a retrospective sentinel surveillance study","volume":"19","author":"Vendrik","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jhin.2026.07.011_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhin.2025.02.012","article-title":"Evaluating the risk of Clostridioides difficile infection from toilet flushing: a quantitative microbial risk assessment and implications for infection control","volume":"159","author":"Paddy","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2026.07.011_bib45","series-title":"Integrated care systems: delivery and improvement","year":"2023"},{"key":"10.1016\/j.jhin.2026.07.011_bib46","series-title":"Clostridioides difficile infections: annual epidemiological report for 2022","year":"2024"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670126002872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670126002872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:50:13Z","timestamp":1789231813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670126002872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S0195670126002872"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2026.07.011","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Escherichia coli bacteraemia, Clostridioides difficile infection and antibiotic prescribing in South West London: a decade of surveillance before and after COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2026.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}